Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03288480
Recruitment Status : Recruiting
First Posted : September 20, 2017
Last Update Posted : September 5, 2019
Sponsor:
Information provided by (Responsible Party):
Phosplatin Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2020
Estimated Study Completion Date : June 30, 2020